| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 234 | $46.94 | $10,984.19 | -0.3% | -6.1% | -39.9% | |
| Sep 20, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 297 | $46.94 | $13,941.48 | -0.3% | -6.1% | -39.9% | |
| Sep 20, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 1,730 | $46.94 | $81,207.93 | -0.3% | -6.1% | -39.9% | |
| Sep 19, 2024 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 5,173 | $35.23 | $182,262.90 | -100% | +12.1% | -3.2% | |
| Sep 18, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | EVP, Gm, Precision Oncology | Sell | 929 | $70.00 | $65,030.00 | -6.4% | -12.8% | -22.6% | |
| Sep 18, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 22,000 | $127.60 | $2,807,237.47 | -2.6% | +32.3% | +41.5% | |
| Sep 16, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,127 | $30.97 | $158,793.44 | -1.9% | -6.9% | -29.7% | |
| Sep 16, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,635 | $37.59 | $99,049.65 | -5.6% | +113.4% | +221.8% | |
| Sep 16, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 94 | $46.42 | $4,363.67 | -0.1% | +4.0% | -41.8% | |
| Sep 16, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,024 | $128.48 | $645,474.05 | -0.5% | +31.7% | +35.0% | |
| Sep 16, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $37.59 | $394,732.59 | -9.2% | +113.4% | +221.8% | |
| Sep 13, 2024 | TTOO T2 Biosystems, Inc. | Elsbree David B | Director | Sell | 55 | $2.42 | $133.10 | -70.5% | - | - | |
| Sep 13, 2024 | NTRA Natera, Inc. | Chapman Rowan E52 | - | Sell | 2,614 | $127.68 | $333,755.52 | -24.7% | +31.6% | +33.2% | |
| Sep 11, 2024 | XWEL Xwell, Inc. | Wizenberg Gaelle Sandra | Director | Buy | 1,201 | $1.65 | $1,986.57 | +401.7% | -16.0% | -35.6% | |
| Sep 11, 2024 | MYGN Myriad Genetics Inc | Muzzey Dale | Chief Scientific Officer | Sell | 2,100 | $26.17 | $54,961.20 | -1.9% | -41.6% | -70.8% | |
| Sep 11, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,616 | $30.32 | $79,317.12 | -0.9% | -4.5% | -26.7% | |
| Sep 11, 2024 | MYGN Myriad Genetics Inc | Diaz Paul J74 | President And CEO | Sell | 15,000 | $26.72 | $400,800.00 | -1.5% | -41.6% | -70.8% | |
| Sep 9, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,639 | $33.33 | $121,287.87 | -3.7% | +116.0% | +273.5% | |
| Sep 9, 2024 | MYGN Myriad Genetics Inc | Dreismann Heinrich | Director | Sell | 10,000 | $27.05 | $270,520.00 | -7.6% | -45.2% | -74.3% | |
| Sep 9, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,586 | $29.46 | $76,175.80 | -0.9% | +5.4% | -16.0% | |
| Sep 9, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 895 | $33.33 | $29,830.35 | -2.2% | +116.0% | +273.5% | |
| Sep 6, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 275 | $39.16 | $10,769.28 | -0.3% | +38.2% | -29.8% | |
| Sep 6, 2024 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 15,000,000 | $15.03 | $225,450,000.00 | -16.9% | -17.1% | -0.2% | |
| Sep 6, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 240 | $39.16 | $9,398.64 | -0.6% | +38.2% | -29.8% | |
| Sep 6, 2024 | BIO Bio-Rad Laboratories, Inc. | Last Andrew J.49 | EVP, Chief Operating Officer | Sell | 3,000 | $329.94 | $989,815.20 | -28.4% | -2.2% | -10.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.